Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors.

Thorac Cancer · 2025 · PMC12443809 · PMID 40963363

Europe PMC DOI

hedged sentence

0.1620

closest p · 3.2× alpha

0.1620

boldest claim

The sentences

did not reach statistical significancep = 0.162not close (p > 0.1)

27.8%), although this difference did not reach statistical significance ( p = 0.162).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.